Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Rheumatology|March 24, 2015
Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literatureKristin M Logee, Santhanam Lakshminarayanan
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 19, 2010
Benign spontaneous pneumoperitoneum in systemic sclerosisJohn Vischio, Zinaida Matlyuk-Urman, Santhanam Lakshminarayanan
Cureus|November 9, 2019
Adalimumab-induced Anti-neutrophilic Cytoplasmic Antibody Vasculitis: A Rare Complication of an Increasingly Common TreatmentTanya Chandra, Joy-Ann Tabanor-Gayle, Santhanam Lakshminarayanan
World Neurosurgery|April 20, 2020
Sarcoid Infiltration of the Skull with Epidural Extension: Case Report and Literature ReviewAnzhela D Moskalik, Melanie R Graber, Santhanam Lakshminarayanan, et al.
Rheumatology International|May 25, 2021
Esophageal dysmotility and lung disease in patients with systemic sclerosis: is there a possible association or correlation? A retrospective chart reviewNavya Kuchipudi, Shweta Kishore, Chia-Ling Kuo, et al.
Immunology|February 2, 2026
BXSB.Yaa: A Translational Model of Toll-Like Receptor 7-Type I Interferon-Driven Systemic Lupus ErythematosusBritney Sison, Colleen M Farley, John J Wilson, et al.
Arthritis Care & Research|April 21, 2025
A Consensus Based Shoulder Examination for Rheumatology TrainingH Berk Degirmenci, Robert Kalish, Ratnesh Chopra, et al.
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Rheumatology (Oxford, England)|October 28, 2017
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosisMichael B Arnold, Dinesh Khanna, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Pageof 2